Scope
This is a focused account of the IDSA 2014 skin and soft-tissue infection guideline. It distinguishes purulent collections requiring drainage, nonpurulent cellulitis, surgical-site infection and rapidly progressive deep infection. Immune status, exposure history, clinical severity and local resistance guide investigation and antimicrobial selection; urgent source control is central in necrotizing disease.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Distinguish impetigo from purulent collections
- For impetigo or ecthyma, culture exudate when useful, although typical cases can be treated without it. Oral treatment is recommended for numerous impetigo lesions or outbreaks, and ecthyma requires oral therapy. [1]
- The source recommends topical mupirocin or retapamulin twice daily for 5 days for impetigo. Oral impetigo or ecthyma therapy lasts 7 days and covers staphylococci unless cultures show streptococci alone; suspected or confirmed MRSA changes agent selection. [1]
- Incision and drainage is the recommended treatment for abscesses, carbuncles, large furuncles and inflamed epidermoid cysts. Culture abscess or carbuncle pus when possible, but typical cases can proceed without it; routine culture of inflamed epidermoid cysts is not recommended. [1]
- In the source abscess pathway, systemic illness informs adjunct antibiotics after drainage. MRSA-active treatment is recommended after failed initial antibiotics, with markedly impaired host defences, or with SIRS and hypotension. Consider systemic therapy also for multiple abscesses, extremes of age or failed drainage alone. [1]
- For recurrent abscesses, look for local causes such as hidradenitis, pilonidal disease or foreign material; drain and culture early. The source weakly suggests 5–10 days of pathogen-directed antibiotics. Investigate neutrophil disorders in adults whose recurrent abscesses began in early childhood. [1]
- For recurrent staphylococcal infection, consider a 5-day decolonization course: intranasal mupirocin twice daily, daily chlorhexidine washing and daily cleaning of personal items. This is a weak recommendation with low-quality evidence, not a guarantee against recurrence. [1]
Treat nonpurulent cellulitis according to severity
- Do not routinely culture uncomplicated cellulitis. Blood cultures are recommended, and aspirate or biopsy cultures considered, with chemotherapy-associated malignancy, neutropenia, severe cellular immune deficiency, immersion injury or animal bites. [1]
- Typical nonpurulent cellulitis without systemic signs needs streptococcal-active therapy. Add coverage for MRSA and streptococci when associated with penetrating trauma, MRSA elsewhere or nasal carriage, injection drug use or SIRS. [1]
- Treat cellulitis for 5 days, extending treatment if improvement is inadequate. Elevate the affected area and address oedema or skin disease; examine and treat fissuring, scaling or maceration between the toes in lower-limb cellulitis. [1]
- Outpatient cellulitis care is appropriate without SIRS, altered mental status or haemodynamic instability. Admit when deeper or necrotizing infection is suspected, adherence is poor, the patient is severely immunocompromised, or outpatient treatment is failing. [1]
- For recurrent cellulitis, treat oedema, obesity, eczema, venous insufficiency and toe-web disease. Consider antibiotic prophylaxis after 3–4 annual episodes despite these measures; the recommendation to initiate prophylaxis is weak, and continuing predisposing factors affect its duration. [1]
Combine source control with the appropriate spectrum
- For surgical-site infection, remove sutures and drain. Systemic antibiotics are not routinely needed after drainage, but significant systemic response can justify them; clean trunk, head/neck or limb operations with systemic infection signs warrant a brief course. [1]
- When antibiotics are indicated for surgical-site infection, choose staphylococcal coverage according to MRSA risk. After axillary, gastrointestinal, perineal or female-genital operations, include gram-negative and anaerobic coverage. [1]
- Obtain prompt surgical consultation for aggressive infection with systemic toxicity or suspected necrotizing fasciitis or gas gangrene. Disproportionate pain, wooden induration, bullae, crepitus or skin necrosis raise suspicion; imaging must not create avoidable delays in definitive treatment. [1]
- For suspected necrotizing infection, give broad empiric therapy covering MRSA, other aerobes and anaerobes. Source examples pair vancomycin or linezolid with piperacillin–tazobactam, a carbapenem, or ceftriaxone plus metronidazole. Documented group-A streptococcal disease calls for penicillin plus clindamycin. [1]
- Necrotizing fasciitis requires debridement when confirmed or suspected. The source advises reassessment in theatre after 24–36 hours and usually daily thereafter until further debridement is unnecessary; antimicrobial duration also depends on clinical improvement and being afebrile for 48–72 hours. [1]
Manage muscle infection urgently
- For pyomyositis, MRI is preferred; obtain blood and abscess cultures and drain pus early. Start vancomycin, adding enteric gram-negative coverage for immunocompromise or open muscle trauma; confirmed MSSA supports cefazolin or an antistaphylococcal penicillin. [1]
- For pyomyositis, begin IV antibiotics; oral transition requires clinical improvement, promptly cleared bacteraemia and no endocarditis or metastatic abscess. The source recommends two to three weeks overall. Persistent bacteraemia requires repeat imaging for undrained infection. [1]
- Suspected gas gangrene requires urgent exploration and debridement with broad initial antibiotics. Confirmed clostridial myonecrosis is treated with penicillin plus clindamycin. The source recommends against hyperbaric oxygen because benefit is unproven and treatment may delay resuscitation or surgery. [1]
Account for exposure and host defences
- For dog or cat bites, give 3–5 days of preemptive antibiotics when there is immunocompromise, asplenia, advanced liver disease, local oedema, moderate-to-severe injury especially of hand or face, or possible periosteal or joint-capsule penetration. [1]
- For infected animal-bite wounds, use aerobic and anaerobic coverage, such as amoxicillin–clavulanate. Assess rabies postexposure needs with local public-health advice and assess tetanus immunization separately; antibiotics do not constitute the complete postexposure pathway. [1]
- Avoid primary closure of animal-bite wounds except selected facial wounds managed with copious irrigation, cautious debridement and preemptive antibiotics. Other wounds may be approximated; these statements have different recommendation strengths. [1]
- In immunocompromised patients, consider noninfectious mimics as well as bacterial, viral, fungal and parasitic infection. Obtain early lesion biopsy or aspiration for histological and microbiological assessment; an innocuous-looking lesion can reflect serious disseminated infection. [1]
- For skin or soft-tissue infection during an initial febrile-neutropenic episode, the source recommends hospital admission and vancomycin plus antipseudomonal treatment, subsequently tailored to isolates. Persistent or recurrent fever with neutropenia and SSTI requires renewed lesion evaluation and addition of empiric antifungal therapy. [1]
Limitations and use
- These are source-specific 2014 recommendations, not a newly updated antibiotic evidence review. Current local susceptibility, newer disease-specific guidance and individual contraindications must inform prescribing.
- This summary omits complete drug doses, paediatric or pregnancy prescribing, rare zoonotic infections and organism-specific fungal regimens. It is not a complete rabies or tetanus postexposure protocol.
- The source prints an anomalous low white-cell threshold in its SIRS list; that numerical list is not reproduced. Do not derive a SIRS scoring rule from this summary.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Diagnosis and management of skin and soft tissue infections
Selected recommendation material consulted
Publication details
- Issuing organisation
- IDSA
- Resource type
- Clinical guideline · House clinical summary
Earlier House summaries: skin and soft tissue infections idsa
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.